Global GABA (CAS 56-12-2) Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 GABA (CAS 56-12-2) Product Introduction
• 1.2 Market by Production Process
  • 1.2.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Production Process
  • 1.2.2 Biological Fermentation
  • 1.2.3 Chemical Synthesis
• 1.3 Market by Application
  • 1.3.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Application
  • 1.3.2 Pharmaceuticals & Food
  • 1.3.3 Animal Feeds
  • 1.3.4 Plants Growth Promoter
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global GABA (CAS 56-12-2) Production

• 2.1 Global GABA (CAS 56-12-2) Production Capacity (2016-2027)
• 2.2 Global GABA (CAS 56-12-2) Production by Region: 2016 VS 2021 VS 2027
• 2.3 Global GABA (CAS 56-12-2) Production by Region
  • 2.3.1 Global GABA (CAS 56-12-2) Historic Production by Region (2016-2021)
  • 2.3.2 Global GABA (CAS 56-12-2) Forecasted Production by Region (2022-2027)
• 2.4 Japan
• 2.5 China

3 Global GABA (CAS 56-12-2) Sales in Volume & Value Estimates and Forecasts

• 3.1 Global GABA (CAS 56-12-2) Sales Estimates and Forecasts 2016-2027
• 3.2 Global GABA (CAS 56-12-2) Revenue Estimates and Forecasts 2016-2027
• 3.3 Global GABA (CAS 56-12-2) Revenue by Region: 2016 VS 2021 VS 2027
• 3.4 Global Top GABA (CAS 56-12-2) Regions by Sales
  • 3.4.1 Global Top GABA (CAS 56-12-2) Regions by Sales (2016-2021)
  • 3.4.2 Global Top GABA (CAS 56-12-2) Regions by Sales (2022-2027)
• 3.5 Global Top GABA (CAS 56-12-2) Regions by Revenue
  • 3.5.1 Global Top GABA (CAS 56-12-2) Regions by Revenue (2016-2021)
  • 3.5.2 Global Top GABA (CAS 56-12-2) Regions by Revenue (2022-2027)
• 3.6 North America
• 3.7 Europe
• 3.8 Asia-Pacific
• 3.9 Latin America
• 3.10 Middle East & Africa

4 Competition by Manufactures

• 4.1 Global GABA (CAS 56-12-2) Supply by Manufacturers
  • 4.1.1 Global Top GABA (CAS 56-12-2) Manufacturers by Production Capacity (2020 VS 2021)
  • 4.1.2 Global Top GABA (CAS 56-12-2) Manufacturers by Production (2016-2021)
• 4.2 Global GABA (CAS 56-12-2) Sales by Manufacturers
  • 4.2.1 Global Top GABA (CAS 56-12-2) Manufacturers by Sales (2016-2021)
  • 4.2.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Sales (2016-2021)
  • 4.2.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Sales in 2020
• 4.3 Global GABA (CAS 56-12-2) Revenue by Manufacturers
  • 4.3.1 Global Top GABA (CAS 56-12-2) Manufacturers by Revenue (2016-2021)
  • 4.3.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Revenue (2016-2021)
  • 4.3.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Revenue in 2020
• 4.4 Global GABA (CAS 56-12-2) Sales Price by Manufacturers
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 4.5.2 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5.3 Global GABA (CAS 56-12-2) Manufacturers Geographical Distribution
• 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

• 5.1 Global GABA (CAS 56-12-2) Sales by Production Process
  • 5.1.1 Global GABA (CAS 56-12-2) Historical Sales by Production Process (2016-2021)
  • 5.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Production Process (2022-2027)
  • 5.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
• 5.2 Global GABA (CAS 56-12-2) Revenue by Production Process
  • 5.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Production Process (2016-2021)
  • 5.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Production Process (2022-2027)
  • 5.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
• 5.3 Global GABA (CAS 56-12-2) Price by Production Process
  • 5.3.1 Global GABA (CAS 56-12-2) Price by Production Process (2016-2021)
  • 5.3.2 Global GABA (CAS 56-12-2) Price Forecast by Production Process (2022-2027)

6 Market Size by Application

• 6.1 Global GABA (CAS 56-12-2) Sales by Application
  • 6.1.1 Global GABA (CAS 56-12-2) Historical Sales by Application (2016-2021)
  • 6.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Application (2022-2027)
  • 6.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
• 6.2 Global GABA (CAS 56-12-2) Revenue by Application
  • 6.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Application (2016-2021)
  • 6.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Application (2022-2027)
  • 6.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
• 6.3 Global GABA (CAS 56-12-2) Price by Application
  • 6.3.1 Global GABA (CAS 56-12-2) Price by Application (2016-2021)
  • 6.3.2 Global GABA (CAS 56-12-2) Price Forecast by Application (2022-2027)

7 North America

• 7.1 North America GABA (CAS 56-12-2) Market Size by Production Process
  • 7.1.1 North America GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
  • 7.1.2 North America GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
• 7.2 North America GABA (CAS 56-12-2) Market Size by Application
  • 7.2.1 North America GABA (CAS 56-12-2) Sales by Application (2016-2027)
  • 7.2.2 North America GABA (CAS 56-12-2) Revenue by Application (2016-2027)
• 7.3 North America GABA (CAS 56-12-2) Sales by Country
  • 7.3.1 North America GABA (CAS 56-12-2) Sales by Country (2016-2027)
  • 7.3.2 North America GABA (CAS 56-12-2) Revenue by Country (2016-2027)
  • 7.3.3 U.S.
  • 7.3.4 Canada

8 Europe

• 8.1 Europe GABA (CAS 56-12-2) Market Size by Production Process
  • 8.1.1 Europe GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
  • 8.1.2 Europe GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
• 8.2 Europe GABA (CAS 56-12-2) Market Size by Application
  • 8.2.1 Europe GABA (CAS 56-12-2) Sales by Application (2016-2027)
  • 8.2.2 Europe GABA (CAS 56-12-2) Revenue by Application (2016-2027)
• 8.3 Europe GABA (CAS 56-12-2) Sales by Country
  • 8.3.1 Europe GABA (CAS 56-12-2) Sales by Country (2016-2027)
  • 8.3.2 Europe GABA (CAS 56-12-2) Revenue by Country (2016-2027)
  • 8.3.3 Germany
  • 8.3.4 France
  • 8.3.5 U.K.
  • 8.3.6 Italy
  • 8.3.7 Russia

9 Asia Pacific

• 9.1 Asia Pacific GABA (CAS 56-12-2) Market Size by Production Process
  • 9.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
  • 9.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
• 9.2 Asia Pacific GABA (CAS 56-12-2) Market Size by Application
  • 9.2.1 Asia Pacific GABA (CAS 56-12-2) Sales by Application (2016-2027)
  • 9.2.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2016-2027)
• 9.3 Asia Pacific GABA (CAS 56-12-2) Sales by Region
  • 9.3.1 Asia Pacific GABA (CAS 56-12-2) Sales by Region (2016-2027)
  • 9.3.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2016-2027)
  • 9.3.3 China
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 India
  • 9.3.7 Australia
  • 9.3.8 Taiwan
  • 9.3.9 Indonesia
  • 9.3.10 Thailand
  • 9.3.11 Malaysia
  • 9.3.12 Philippines

10 Latin America

• 10.1 Latin America GABA (CAS 56-12-2) Market Size by Production Process
  • 10.1.1 Latin America GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
  • 10.1.2 Latin America GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
• 10.2 Latin America GABA (CAS 56-12-2) Market Size by Application
  • 10.2.1 Latin America GABA (CAS 56-12-2) Sales by Application (2016-2027)
  • 10.2.2 Latin America GABA (CAS 56-12-2) Revenue by Application (2016-2027)
• 10.3 Latin America GABA (CAS 56-12-2) Sales by Country
  • 10.3.1 Latin America GABA (CAS 56-12-2) Sales by Country (2016-2027)
  • 10.3.2 Latin America GABA (CAS 56-12-2) Revenue by Country (2016-2027)
  • 10.3.3 Mexico
  • 10.3.4 Brazil
  • 10.3.5 Argentina

11 Middle East and Africa

• 11.1 Middle East and Africa GABA (CAS 56-12-2) Market Size by Production Process
  • 11.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
  • 11.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
• 11.2 Middle East and Africa GABA (CAS 56-12-2) Market Size by Application
  • 11.2.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2016-2027)
  • 11.2.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2016-2027)
• 11.3 Middle East and Africa GABA (CAS 56-12-2) Sales by Country
  • 11.3.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2016-2027)
  • 11.3.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2016-2027)
  • 11.3.3 Turkey
  • 11.3.4 Saudi Arabia
  • 11.3.5 U.A.E

12 Corporate Profiles

• 12.1 Pharma Foods International
  • 12.1.1 Pharma Foods International Corporation Information
  • 12.1.2 Pharma Foods International Overview
  • 12.1.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pharma Foods International GABA (CAS 56-12-2) Product Description
  • 12.1.5 Pharma Foods International Related Developments
• 12.2 Kyowa Hakko
  • 12.2.1 Kyowa Hakko Corporation Information
  • 12.2.2 Kyowa Hakko Overview
  • 12.2.3 Kyowa Hakko GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Kyowa Hakko GABA (CAS 56-12-2) Product Description
  • 12.2.5 Kyowa Hakko Related Developments
• 12.3 Sekisui Chemical
  • 12.3.1 Sekisui Chemical Corporation Information
  • 12.3.2 Sekisui Chemical Overview
  • 12.3.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Sekisui Chemical GABA (CAS 56-12-2) Product Description
  • 12.3.5 Sekisui Chemical Related Developments
• 12.4 Zhejiang YiWan Biolabs
  • 12.4.1 Zhejiang YiWan Biolabs Corporation Information
  • 12.4.2 Zhejiang YiWan Biolabs Overview
  • 12.4.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product Description
  • 12.4.5 Zhejiang YiWan Biolabs Related Developments
• 12.5 Shanghai Richen
  • 12.5.1 Shanghai Richen Corporation Information
  • 12.5.2 Shanghai Richen Overview
  • 12.5.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Shanghai Richen GABA (CAS 56-12-2) Product Description
  • 12.5.5 Shanghai Richen Related Developments
• 12.6 Guangdong Luckerkong Biotech
  • 12.6.1 Guangdong Luckerkong Biotech Corporation Information
  • 12.6.2 Guangdong Luckerkong Biotech Overview
  • 12.6.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Product Description
  • 12.6.5 Guangdong Luckerkong Biotech Related Developments
• 12.7 Tianjin Shijitianlong Biotech
  • 12.7.1 Tianjin Shijitianlong Biotech Corporation Information
  • 12.7.2 Tianjin Shijitianlong Biotech Overview
  • 12.7.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product Description
  • 12.7.5 Tianjin Shijitianlong Biotech Related Developments
• 12.8 Ningxiang Jiayuan Biology Technology
  • 12.8.1 Ningxiang Jiayuan Biology Technology Corporation Information
  • 12.8.2 Ningxiang Jiayuan Biology Technology Overview
  • 12.8.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product Description
  • 12.8.5 Ningxiang Jiayuan Biology Technology Related Developments
• 12.9 Zhejiang Tianrui Chemical
  • 12.9.1 Zhejiang Tianrui Chemical Corporation Information
  • 12.9.2 Zhejiang Tianrui Chemical Overview
  • 12.9.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product Description
  • 12.9.5 Zhejiang Tianrui Chemical Related Developments
• 12.10 Taizhou Xinyou Pharmaceutical & Chemical
  • 12.10.1 Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
  • 12.10.2 Taizhou Xinyou Pharmaceutical & Chemical Overview
  • 12.10.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product Description
  • 12.10.5 Taizhou Xinyou Pharmaceutical & Chemical Related Developments
• 12.11 Bloomage Biotechnology Corporation Limited
  • 12.11.1 Bloomage Biotechnology Corporation Limited Corporation Information
  • 12.11.2 Bloomage Biotechnology Corporation Limited Overview
  • 12.11.3 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Product Description
  • 12.11.5 Bloomage Biotechnology Corporation Limited Related Developments
• 12.12 Bornsun Bioengineering
  • 12.12.1 Bornsun Bioengineering Corporation Information
  • 12.12.2 Bornsun Bioengineering Overview
  • 12.12.3 Bornsun Bioengineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Bornsun Bioengineering GABA (CAS 56-12-2) Product Description
  • 12.12.5 Bornsun Bioengineering Related Developments
• 12.13 Luoyang Huarong
  • 12.13.1 Luoyang Huarong Corporation Information
  • 12.13.2 Luoyang Huarong Overview
  • 12.13.3 Luoyang Huarong GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Luoyang Huarong GABA (CAS 56-12-2) Product Description
  • 12.13.5 Luoyang Huarong Related Developments
• 12.14 Anhui Xinnuobei
  • 12.14.1 Anhui Xinnuobei Corporation Information
  • 12.14.2 Anhui Xinnuobei Overview
  • 12.14.3 Anhui Xinnuobei GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Anhui Xinnuobei GABA (CAS 56-12-2) Product Description
  • 12.14.5 Anhui Xinnuobei Related Developments
• 12.15 Hefei Maikeluo Biological Engineering
  • 12.15.1 Hefei Maikeluo Biological Engineering Corporation Information
  • 12.15.2 Hefei Maikeluo Biological Engineering Overview
  • 12.15.3 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Product Description
  • 12.15.5 Hefei Maikeluo Biological Engineering Related Developments
• 12.16 Hangzhou Viablife Biotech
  • 12.16.1 Hangzhou Viablife Biotech Corporation Information
  • 12.16.2 Hangzhou Viablife Biotech Overview
  • 12.16.3 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Product Description
  • 12.16.5 Hangzhou Viablife Biotech Related Developments
• 12.17 Guangxi Hanhe Biotech
  • 12.17.1 Guangxi Hanhe Biotech Corporation Information
  • 12.17.2 Guangxi Hanhe Biotech Overview
  • 12.17.3 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Product Description
  • 12.17.5 Guangxi Hanhe Biotech Related Developments

13 Industry Chain and Sales Channels Analysis

• 13.1 GABA (CAS 56-12-2) Industry Chain Analysis
• 13.2 GABA (CAS 56-12-2) Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 GABA (CAS 56-12-2) Production Mode & Process
• 13.4 GABA (CAS 56-12-2) Sales and Marketing
  • 13.4.1 GABA (CAS 56-12-2) Sales Channels
  • 13.4.2 GABA (CAS 56-12-2) Distributors
• 13.5 GABA (CAS 56-12-2) Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 14.1 GABA (CAS 56-12-2) Industry Trends
• 14.2 GABA (CAS 56-12-2) Market Drivers
• 14.3 GABA (CAS 56-12-2) Market Challenges
• 14.4 GABA (CAS 56-12-2) Market Restraints

15 Key Finding in The Global GABA (CAS 56-12-2) Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source